Citadel Advisors’s ZELTIQ Aesthetics, Inc. ZLTQ Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2017
Q2 | – | Sell |
-17,400
| Closed | -$968K | – | 8554 |
|
|
2017
Q1 | $968K | Sell |
17,400
-2,300
| -12% | -$115K | ﹤0.01% | 4045 |
|
|
2016
Q4 | $857K | Sell |
19,700
-17,200
| -47% | -$693K | ﹤0.01% | 4063 |
|
|
2016
Q3 | $1.45M | Buy |
36,900
+26,700
| +262% | +$954K | ﹤0.01% | 3370 |
|
|
2016
Q2 | $279K | Sell |
10,200
-5,900
| -37% | -$166K | ﹤0.01% | 5333 |
|
|
2016
Q1 | $437K | Buy |
16,100
+6,800
| +73% | +$160K | ﹤0.01% | 4593 |
|
|
2015
Q4 | $265K | Buy |
9,300
+800
| +9% | +$25.3K | ﹤0.01% | 5409 |
|
|
2015
Q3 | $272K | Sell |
8,500
-2,300
| -21% | -$76.2K | ﹤0.01% | 5717 |
|
|
2015
Q2 | $318K | Hold |
10,800
| – | – | ﹤0.01% | 5667 |
|
|
2015
Q1 | $333K | Buy |
10,800
+7,700
| +248% | +$246K | ﹤0.01% | 5498 |
|
|
2014
Q4 | $87K | Sell |
3,100
-24,400
| -89% | -$635K | ﹤0.01% | 6761 |
|
|
2014
Q3 | $622K | Buy |
27,500
+4,700
| +21% | +$93.1K | ﹤0.01% | 4347 |
|
|
2014
Q2 | $346K | Buy |
22,800
+4,100
| +22% | +$70.1K | ﹤0.01% | 4857 |
|
|
2014
Q1 | $367K | Buy |
18,700
+14,800
| +379% | +$289K | ﹤0.01% | 4772 |
|
|
2013
Q4 | $74K | Buy |
+3,900
| New | +$55.7K | ﹤0.01% | 5823 |
|
Other funds holding ZLTQ
Citadel Advisors's ZLTQ Position: Q1 2017 in Review
Citadel Advisors sold out of ZELTIQ Aesthetics, Inc. (ZLTQ) in Q1 2017, closing a stake of 746,105 shares — an estimated $37.4M sold.
Citadel Advisors first reported a position in ZLTQ in Q2 2013 and held it in 14 quarters. The position peaked at $32.5M in Q4 2016. 194 funds tracked by Wall St. Rank hold ZLTQ as of Q1 2017.
- Citadel Advisors reported no remaining ZELTIQ Aesthetics, Inc. position as of Q1 2017 after selling out during the quarter.
- Citadel Advisors sold 746,105 ZELTIQ Aesthetics, Inc. shares in Q1 2017, an estimated $37.4M.
- Citadel Advisors first reported a position in ZELTIQ Aesthetics, Inc. in Q2 2013 and held it in 14 quarters.
- Citadel Advisors's ZELTIQ Aesthetics, Inc. position peaked at $32.5M in Q4 2016.
- 194 funds tracked by Wall St. Rank held ZELTIQ Aesthetics, Inc. as of Q1 2017.
Based on Citadel Advisors's 13F filing for Q1 2017, filed 12 May 2017.